reboxetine has been researched along with Neurally Mediated Faint in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lei, LY; Raj, SR; Sheldon, RS | 1 |
| Cárdenas, M; Gómez-Flores, JR; González-Hermosillo, JA; Márquez, MF; Ruíz-Siller, TJ | 1 |
2 review(s) available for reboxetine and Neurally Mediated Faint
| Article | Year |
|---|---|
Pharmacological norepinephrine transporter inhibition for the prevention of vasovagal syncope in young and adult subjects: A systematic review and meta-analysis.
Topics: Adult; Cardiac Output; Heart Rate; Humans; Norepinephrine Plasma Membrane Transport Proteins; Quality of Life; Reboxetine; Syncope, Vasovagal; Young Adult | 2020 |
[Role of the sympathetic nervous system in vasovagal syncope and rationale for beta-blockers and norepinephrine transporter inhibitors].
Topics: Adrenergic beta-Antagonists; Baroreflex; Cyclobutanes; Heart Rate; Humans; Molecular Biology; Morpholines; Norepinephrine Plasma Membrane Transport Proteins; Reboxetine; Sympathetic Nervous System; Syncope, Vasovagal | 2016 |